Join the movement to end censorship by Big Tech. StopBitBurning.com needs donations and support.
Project Veritas reveals hospitals use non-approved, DANGEROUS drug on COVID-19 patients - Brighteon.TV
By maryvillarealdw // 2021-09-27
Mastodon
    Parler
     Gab
 
In her latest episode of Freedom Force Battalion, Melissa Redpill shares her latest takes on current events One of the topics that Redpill takes on is the exposure of what's been going on in hospitals. A nurse from the U.S. Department of Health and Human Services (HHS) claimed that a man came to the hospital a few days after his second dose of the vaccine with shortness of breath. He had to be put on a ventilator as his lungs started to shut down. In a video, the nurse interviewed a doctor from the HHS, who told her that "the government doesn't want to show that the darn vaccine is full of sh*t."

Hospitals use non-approved drug on COVID-19 patients

Hospitals have also been using a non-approved drug, remdesivir, for COVID-19 patients. Remdesivir is a drug known to stop kidneys from functioning. A study showed that in a clinical trial, kidney injury occurred in 22.8 percent of patients, and proved to be the most frequent cause of the discontinuation of the treatment. The most reported effects of remdesivir in COVID-19 patients include kidney injury, renal impairment, renal failure, and renal tubular necrosis. In a separate study, 62 percent of COVID-19 patients have been found to have viral pneumonia, but over a tenth of them present with bacterial pneumonia. Viral pneumonia is more frequent in the remdesivir group. The use of remdesivir failed to reduce the 14-day mortality rates compared to the control groups. The World Health Organization itself issued a conditional recommendation against the use of remdesivir in hospitalized patients, as there is no real evidence that it improves survival or other outcomes in COVID-19 patients. Evidence suggested that there is no important effect on mortality, need for ventilation, time to clinical improvement, or other patient-important outcomes with the use of remdesivir, yet hospitals have been giving them to patients. The WHO's guideline development group recognized that more research is needed because there is not enough evidence to support the use of remdesivir for severely affected COVID-19 patients. The decision to incorporate remdesivir into the treatment of severe COVID-19 cases was based on reviews gathered by the National Institute for Health and Care Excellence (NICE), in a prepping analysis of data that is yet to be peer-reviewed. However, it showed that remdesivir does not show efficacy in regulating the severity of COVID-19. (Related: Did Fauci knowingly fast-track approval of drug with deadly COVID-like side effects?)

Project Veritas drops bombshells

Project Veritas does undercover journalism work that exposes the lies of the government, and lately, the big issue has been on vaccines. A video from Project Veritas featured Jodi O'Malley, a registered nurse who works for the Indian Health Service in Arizona, and her interview with a doctor named Maria Gonzales. In the video, Gonzales said, "All this is bullshit. Now, [a patient] probably [has] myocarditis due to the vaccine. But now, they are not going to blame the vaccine. They are not reporting it. They want to shove it under the mat." There should be little doubt about vaccines -- the government is expected to share with the public fully and completely the complications that arise upon inoculation. With the government instituting mandates around vaccines, it is important that the population is aware of all the side effects that come with them, to ensure that they know whether or not it is a good idea for their body. Catch Melissa Redpill on her Brighteon.TV channel, Freedom Force Batallion. It airs on BrighteonTV at 11 a.m. Get more updates about COVID-19, vaccines, and alternative treatments at Pandemic.news. Sources include: Brighteon.com ACPT.OnlineLibrary.Wiley.com News-Medical.net WHO.int FirstDraftNews.org ClayAndBuck.com
Mastodon
    Parler
     Gab